Skip to main content
. 2002 Jun;184(12):3242–3252. doi: 10.1128/JB.184.12.3242-3252.2002

TABLE 2.

Heparin-, heparan sulfate-, and chondroitin sulfate-degrading activities in native and transconjugant F. heparinum strainsa

Growth medium Activity (mIU ml−1 OD600−1)b
Hc
HS CSA
CSC
DS
MHd MA MH MH MA MH MA MH MA
Native 158 ± 12 102 ± 10 107 ± 9 15 ± 1 99 ± 9 13 ± 1 72 ± 9 30 ± 2 64 ± 5
FIBX1 126 ± 8 100 ± 4 93 ± 7 14 ± 2 115 ± 4 12 ± 2 82 ± 5 27 ± 2 96 ± 14
FIBX3 144 ± 31 NDe 174 ± 24 ND ND ND ND ND ND
FIBX4 179 ± 13 ND 844 ± 37 ND ND ND ND ND ND
FIBX5 775 ± 89 ND 63 ± 4 ND ND ND ND ND ND
FIBX6 119 ± 19 110 ± 7 ND 2,376 ± 135 4,057 ± 254 1,510 ± 87 2,620 ± 399 59 ± 4 126 ± 9
FIBX7 143 ± 12 104 ± 10 ND 23 ± 3 111 ± 4 14 ± 3 72 ± 2 927 ± 134 958 ± 97
a

Values are the average of three separate experiments ± the standard error.

b

One international unit of GAG-degrading activity is defined as the amount of enzyme that will produce 1 μmol of product per min at 30°C at pH 8.

c

Substrates for GAG lyases' activity assay: H, heparin; HS, heparan sulfate; CSA, chondroitin sulfate A; CSC, chondroitin sulfate C; and DS, dermatan sulfate.

d

Media used in this study. MH, FM supplemented with 1% heparin; and MA, FM supplemented with 1% chondroitin sulfate A.

e

ND, not determined.